title: Upon closer inspection. As the U.S. imports more drugs and devices, the FDA's overseas initiatives aim to head off trouble at the source.
authors.forename: Shawn
authors.initials: S
authors.lastname: Rhea
mesh_terms: D003132:Commerce / Q000331:legislation & jurisprudence*; D004345:Drug Industry / Q000331:legislation & jurisprudence*; D004864:Equipment and Supplies / Q000592:standards*; D006801:Humans; D004364:Pharmaceutical Preparations / Q000592:standards*; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D004364:Pharmaceutical Preparations